We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Guidance and reports on the Department for Transport's trial of longer semi-trailers for articulated goods vehicles.
How investigators and sponsors should manage clinical trials during COVID-19
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
A complete list of 5G projects involved in the 5G Testbeds and Trials Programme
Details of dates when trials are likely to take place at the Chancery division of the High Court.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Details of the earliest available dates for hearings and trials at the King's Bench Division of the High Court, based on how long they are expected to last.
How to use a before-and-after study to evaluate your digital health product.
What to do if you're asked to do jury service - taking time off work, delaying jury service, claiming expenses. Includes information from the withdrawn 5222, 5222A and Juror Charter guidance.
How to use a quasi-experimental study to evaluate your digital health product.
Information about the requirement for selected schools to participate in statutory national curriculum test trials
How to use an interrupted time series to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).